Hochschulschrift
Mechanism of resistance to targeted therapies and chemotherapies in vivo and in vitro in B-ALL
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
184 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Albert-Ludwigs-University Freiburg, Germany, Dissertation, 2023
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:06 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- September 2023
Ähnliche Objekte (12)
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Prostate cancer stem cells: Clinical aspects and targeted therapies
Mouse models and targeted therapies for RAS-driven tumours
The role of microRNAs in resistance to targeted therapies in breast cancer
Developing targeted therapies for pediatric PFA ependymoma
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
Clinical trial designs for predictive marker validation and targeted cancer therapies [Abstract]
Mode of action and resistance mechanism of griselimycin
Dietary Influence, Novel Targeted Therapies, and Richter Transformation in Chronic Lymphocytic Leukemia: Insights and Potential Strategies
Targeted therapies in cancer : with 25 tables ; [indexed in current contents and index medicus]
Targeted therapies for the treatment of triple-negative breast cancer
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Prostate cancer stem cells: Clinical aspects and targeted therapies
Mouse models and targeted therapies for RAS-driven tumours
The role of microRNAs in resistance to targeted therapies in breast cancer
Developing targeted therapies for pediatric PFA ependymoma
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
Clinical trial designs for predictive marker validation and targeted cancer therapies [Abstract]
Mode of action and resistance mechanism of griselimycin
Dietary Influence, Novel Targeted Therapies, and Richter Transformation in Chronic Lymphocytic Leukemia: Insights and Potential Strategies
Targeted therapies in cancer : with 25 tables ; [indexed in current contents and index medicus]
Targeted therapies for the treatment of triple-negative breast cancer
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Prostate cancer stem cells: Clinical aspects and targeted therapies
Mouse models and targeted therapies for RAS-driven tumours
The role of microRNAs in resistance to targeted therapies in breast cancer
Developing targeted therapies for pediatric PFA ependymoma
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
Clinical trial designs for predictive marker validation and targeted cancer therapies [Abstract]
Mode of action and resistance mechanism of griselimycin
Dietary Influence, Novel Targeted Therapies, and Richter Transformation in Chronic Lymphocytic Leukemia: Insights and Potential Strategies
Targeted therapies in cancer : with 25 tables ; [indexed in current contents and index medicus]